Skip to main content

Table 2 Characteristics of nine post-LT HEV seroconverting patients with a history of HCV infection

From: Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States

 

Age at LT

Gender

Ethnicity

LT year

Type of serologic conversion

Conversion year (from LT)

Post-LT HCV treatment

Treatment year post-LT

Treatment medication

Pt 1

46

Male

Caucasian

1998

IgM

5

Yes

1-5

IFN + RBV

Pt 2

48

Male

Caucasian

1998

IgG

1

Yes

0-1

IFN + RBV

Pt 3

39

Male

Native Hawaiian

2000

IgG

5

Yes

2-3

IFN + RBV

Pt 4

36

Female

Caucasian

2001

IgG

1

Yes

0-1

IFN + RBV

Pt 5

47

Male

Other NS

2001

IgG

1

Yes

0

IFN

Pt 6

51

Male

Caucasian

2001

IgG

5

Yes

2-4

IFN + RBV

Pt 7

47

Male

Caucasian

2003

IgG

3

Yes

1-4

IFN + RBV

Pt 8

51

Male

Caucasian

2004

IgG

5

Yes

0-3

IFN + RBV

Pt 9

54

Male

Caucasian

2009

IgG

1

No

N/A

N/A

  1. LT Liver transplant, HEV Hepatitis E virus, HCV Hepatitis C virus, IFN (peg) interferon, RBV ribavirin, Other NS Other than Caucasian, Hispanic, Black or Asian, not specified, N/A not applicable